OS Therapies Inc (OSTX) stock
OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.01 (-0.68%)
Close on Nov 13, 2026Market cap $34.36MP/E –Yield –
OS Therapies cash
Cash and short-term investments held at the end of each period.
OS Therapies's cash was $205.04K at Jun 30, 2026. For fiscal 2025 it was $269.83K, down 95.1% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $269.83K | -95.1% |
| FY2024 | Dec 31, 2024 | $5.53M | +14095.1% |
| FY2023 | Dec 31, 2023 | $38.98K | -77.3% |
| FY2022 | Dec 31, 2022 | $171.48K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $205.04K | -92.7% |
| Q1 FY2026 | Mar 31, 2026 | $917.55K | -69.1% |
| Q4 FY2025 | Dec 31, 2025 | $269.83K | -95.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.88M | +1.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.80M | +2851.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.97M | +2864.2% |
| Q4 FY2024 | Dec 31, 2024 | $5.53M | +14095.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.86M | +11470.5% |
| Q2 FY2024 | Jun 30, 2024 | $94.93K | +92.9% |
| Q1 FY2024 | Mar 31, 2024 | $100.23K | -71.8% |
| Q4 FY2023 | Dec 31, 2023 | $38.98K | -77.3% |
| Q3 FY2023 | Sep 30, 2023 | $16.06K | – |
| Q2 FY2023 | Jun 30, 2023 | $49.22K | – |
| Q1 FY2023 | Mar 31, 2023 | $355.21K | – |
| Q4 FY2022 | Dec 31, 2022 | $171.48K | – |
See a number that looks wrong?